185 related articles for article (PubMed ID: 33709497)
21. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
22. Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers.
Dong Z; Hu R; Du Y; Tan L; Li L; Du J; Bai L; Ma Y; Cui H
Front Immunol; 2020; 11():586796. PubMed ID: 33488587
[TBL] [Abstract][Full Text] [Related]
23. The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
Syst Rev; 2020 Apr; 9(1):88. PubMed ID: 32321580
[TBL] [Abstract][Full Text] [Related]
24. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
Préaud E; Largeron N
J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.
Insinga RP; Liaw KL; Johnson LG; Madeleine MM
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1611-22. PubMed ID: 18628412
[TBL] [Abstract][Full Text] [Related]
26. Molecular targets for therapeutic interventions in human papillomavirus-related cancers (review).
Saito Ramalho A; Dantas Lopes A; Talans A; Parlato Sakiyama BY; Stelko Pereira GL; Hoff PM; De Castro G
Oncol Rep; 2010 Dec; 24(6):1419-26. PubMed ID: 21042735
[TBL] [Abstract][Full Text] [Related]
27. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
28. The Role of Nursing in Preventing HPV-Related Cancers.
Baldwin CM
Clin J Oncol Nurs; 2020 Oct; 24(5):471. PubMed ID: 32945790
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy for HPV Malignancies.
Lee MY; Allen CT
Semin Radiat Oncol; 2021 Oct; 31(4):361-370. PubMed ID: 34455991
[TBL] [Abstract][Full Text] [Related]
30. Human Papillomavirus-Associated Cancers.
Alhamlan FS; Alfageeh MB; Al Mushait MA; Al-Badawi IA; Al-Ahdal MN
Adv Exp Med Biol; 2021; 1313():1-14. PubMed ID: 34661888
[TBL] [Abstract][Full Text] [Related]
31. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
Kwon EJ; Ha M; Jang JY; Kim YH
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
[TBL] [Abstract][Full Text] [Related]
32. The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.
Zhang L; Wu J; Ling MT; Zhao L; Zhao KN
Mol Cancer; 2015 Apr; 14():87. PubMed ID: 26022660
[TBL] [Abstract][Full Text] [Related]
33. New insights in Hippo signalling alteration in human papillomavirus-related cancers.
Olmedo-Nieva L; Muñoz-Bello JO; Manzo-Merino J; Lizano M
Cell Signal; 2020 Dec; 76():109815. PubMed ID: 33148514
[TBL] [Abstract][Full Text] [Related]
34. Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.
Dillner J; Arbyn M; Dillner L
Clin Exp Immunol; 2007 May; 148(2):199-207. PubMed ID: 17437418
[TBL] [Abstract][Full Text] [Related]
35. [Vaccination against human papillomavirus].
Hillemanns P; Kampers J; Hachenberg J; Jentschke M
Internist (Berl); 2021 Aug; 62(8):816-826. PubMed ID: 34259907
[TBL] [Abstract][Full Text] [Related]
36. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
37. [Human papillomavirus types and their related diseases].
Wang H; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):678-84. PubMed ID: 18051728
[TBL] [Abstract][Full Text] [Related]
38. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana.
Rantshabeng PS; Moyo S; Moraka NO; Ndlovu A; MacLeod IJ; Gaseitsiwe S; Kasvosve I
BMC Infect Dis; 2017 Nov; 17(1):731. PubMed ID: 29178840
[TBL] [Abstract][Full Text] [Related]
40. The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer.
Shibata T; Lieblong BJ; Sasagawa T; Nakagawa M
Cancer Treat Rev; 2019 Aug; 78():8-16. PubMed ID: 31302573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]